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There is a critical need for flexible, rapid, cost effective biomanufacturing platforms for medical 
countermeasures. Our team has developed plant cell culture-based manufacturing platforms for production of 
recombinant protein bioscavengers against organophosphate (OP) nerve agents and anthrax toxins using both 
stable transgenic cell cultures for known chemical and biological threats, as well as transient production for rapid 
response to new and/or unanticipated threats.  Plant cells offer several advantages over other hosts for 
production of medical countermeasures, particularly their ability to produce complex biologics and perform post-
translational modification, inherent biosafety since they don't harbor or propagate mammalian viruses thereby 
simplifying and/or eliminating viral clearance steps required for mammalian production systems.  Plant cells are 
robust, have minimal nutrient requirements (grow in simple, chemically defined media containing sucrose, salts 
and plant hormones), and are relatively insensitive to changes in environmental conditions.  These 
characteristics, robustness of upstream cultivation/use and reduced downstream purification requirements, 
make plant cells an ideal choice for field-deployable production of medical countermeasures. Here we present 
results for the production of functional recombinant butyrylcholinesterase (BChE), an OP nerve agent 
bioscavenger, in transgenic rice cell suspension cultures in different bioreactor configurations, and transient 
production of a bioscavenger against an anthrax toxin in N. benthamiana cell cultures. Techno-economic 
models for scaled-up versions of these plant cell culture production systems will also be presented. 
 
